OS Cancer Research Results
OS, overall survival: Click to Expand ⟱
| Source: |
| Type: |
Overall survival
|
Scientific Papers found: Click to Expand⟱
| - |
Trial, |
NSCLC, |
NA |
|
|
|
- |
Trial, |
PC, |
NA |
|
|
|
- |
Trial, |
HCC, |
NA |
|
|
|
Dose↝, toxicity↓, other↓, QoL↑, OS?,
*antiOx↑, *lipid-P↓, *TNF-α↓, *NF-kB↓, *COX2↓, *IronCh↑, P53↓, TumCCA↑, HSPs↓, P21↓, RAS↓, ER(estro)↑, OS?,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Transcription & Epigenetics ⓘ
other↓, 1,
Protein Folding & ER Stress ⓘ
HSPs↓, 1,
DNA Damage & Repair ⓘ
P53↓, 1,
Cell Cycle & Senescence ⓘ
P21↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
RAS↓, 1,
Hormonal & Nuclear Receptors ⓘ
ER(estro)↑, 1,
Drug Metabolism & Resistance ⓘ
Dose↝, 1,
Functional Outcomes ⓘ
OS?, 2, QoL↑, 1, toxicity↓, 1,
Total Targets: 11
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, lipid-P↓, 1,
Metal & Cofactor Biology ⓘ
IronCh↑, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, NF-kB↓, 1, TNF-α↓, 1,
Total Targets: 6
Scientific Paper Hit Count for: OS, overall survival
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:229 State#:% Dir#:0
wNotes=0 sortOrder:rid,rpid
Home Page